Organon & Co. (OGN)
9.76
+0.02
(+0.21%)
USD |
NYSE |
Jan 23, 16:00
9.89
+0.13
(+1.33%)
After-Hours: 20:00
Organon Research and Development Expense (TTM): 405.00M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Merck & Co., Inc. | 14.26B |
| Rockwell Medical, Inc. | 0.001M |
| Plus Therapeutics, Inc. | 7.624M |
| Geron Corp. | 81.32M |
| Regeneron Pharmaceuticals, Inc. | 5.097B |